Nu najis asam amino anu dianggo pikeun sintésis protéin
Jénmén produk
| NO | Produk | Kasuhan henteu | Indikator kualitas konci | |||
| Kasadi | Max. impuri | Jumlah sésa garansi | Kandungan cai | |||
| 1 | Fmoc-β-ala-ala-oh | NA | ≥9.0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 2 | Fmoc-d-ala-d-ala-oh | NA | ≥9.0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 3 | Fmoc-β-ala-d-ala-oh | NA | ≥9.0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 4 | Fmoc-arg (pbf) -ARG (pbf) -oh | NA | ≥9.0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 5 | Fmoc-β-ala-arg (pbf) -oh | NA | ≥9.0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 6 | Fmoc-d-art (pbf) -D -D - pbf) -oh | NA | ≥9.0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 7 | Fmoc-β-ala-d-d-art (pbf) -oh | NA | ≥9.0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 8 | Fmoc-homoarg (pbf) -homoarg (pbf) -oh | NA | ≥9.0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 9 | Fmoc-β-ala-homoarg (pbf) -oh | NA | ≥9.0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 10 | Fmoc-asn (trt) -asn (trt) -oh | NA | ≥9.0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 11 | Fmoc-β-ala-ASN (trt) -oh | NA | ≥9.0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 12 | Fmoc-cita (OTBU)-terep (otbu) -oh | NA | ≥9.0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 13 | FMOC-β-ala-cita (otbu) -oh | NA | ≥9.0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 14 | Fmoc-cys (trt) -cys (trt) -oh | NA | ≥9.0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 15 | Fmoc-β-ala-cys (trt) -oh | NA | ≥9.0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 16 | FMOC-CYY (ACM) -cys (ACM) -oh | NA | ≥9.0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 17 | Fmoc-β-ala-cys (acm) -oh | NA | ≥9.0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 18 | Fmoc-gln (trt) -Gn (trt) -oh | NA | ≥9.0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 19 | Fmoc-β-ala-gln (trt) -oh | NA | ≥9.0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 20 | FMOC-Glu (OTBU) -Gu (OTBU) -oh | NA | ≥9.0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 21 | Fmoc-β-ala-glu (Otbu) -O.H2O | NA | ≥9.0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 22 | Fmoc-β-ala-gly-oh | NA | ≥9.0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 23 | Fmoc-nya (trt) -His (trt) -oh | NA | ≥9.0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 24 | Fmoc-β-ala-na (trt) -oh | NA | ≥9.0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 25 | Fmoc-ilh-emp-Oh | NA | ≥9.0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 26 | Fmoc-β-ala-asi-oh | NA | ≥9.0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 27 | Fmoc-lu-lu'i-oh | NA | ≥9.0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 28 | FMOC-β-ala-lu-th | NA | ≥9.0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 29 | FMOC-D-Leuwna-D-Leuwna | NA | ≥9.0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 30 | Fmoc-β-ala-d-leo-oh | NA | ≥9.0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 31 | Fmoc-lys (boc) -ly (boc) - -oh | NA | ≥9.0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 32 | Fmoc-β-ala-lys (boc) -oh | NA | ≥9.0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 33 | Fmoc-lys (alloc) -ly (alloc) -oh | NA | ≥9.0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 34 | Fmoc-β-ala-lys (alloc) -oh | NA | ≥9.0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 35 | Fmoc-tepang-oh | NA | ≥9.0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 36 | Fmoc-β-ala-patep-oh | NA | ≥9.0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 37 | FMOC-orn (boc) - boc) - -oh | NA | ≥9.0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 38 | Fmoc-β-ala-orn (boc) -O | NA | ≥9.0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 39 | Fmoc-fm-phe-oh | NA | ≥9.0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 40 | Fmoc-β-ala-phe-oh | NA | ≥9.0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 41 | Fmoc-d-ph-d-phe-oh | NA | ≥9.0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 42 | Fmoc-β-ala-d-phe-oh | NA | ≥9.0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 43 | Fmoc-pro-pro-oh | NA | ≥9.0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 44 | Fmoc-β-ala-pro-pro | NA | ≥9.0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 45 | Fmoc-ser (tbu) -ser (tbu) -oh | NA | ≥9.0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 46 | Fmoc-β-ala-ser (tbu) -oh | NA | ≥9.0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 47 | FMOC-Sern (trt) -ser (trt) -oh | NA | ≥9.0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 48 | Fmoc-β-ala-ser (trt) -oh | NA | ≥9.0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 49 | Fmoc-th (tbu) -th (tbu) -oh | NA | ≥9.0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 50 | Fmoc-β-ala-tha (tbu) -oh | NA | ≥9.0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 51 | Fmoc-trp (boc) -trp (boc) - -oh | NA | ≥9.0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 52 | Fmoc-β-ala-trP (boc) -oh | NA | ≥9.0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 53 | FMOC-D-Trp (boc)-boc) (boc) -oh | NA | ≥9.0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 54 | Fmoc-β-ala-d-d1 (boc) - -oh | NA | ≥9.0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 55 | FMOC-Tyr (Tbu) -tyr (TBU) -oh | NA | ≥9.0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 56 | Fmoc-β-ala-tyr (tbu) -oh | NA | ≥9.0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 57 | FMOC-D-tyr (et) -d)-tyy (et) -oh | NA | ≥9.0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 58 | Fmoc-β-ala-d-tyr (et) -oh | NA | ≥9.0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 59 | Fmoc-tyr (kuring) -tyr (kuring) -oh | NA | ≥9.0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 60 | Fmoc-β-ala-tyr (kuring) -oh | NA | ≥9.0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 61 | FMOC-VAL-VAL - OH | NA | ≥9.0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 62 | Fmoc-β-ala-val-oh | NA | ≥9.0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 63 | Fmoc-d-cit-d-cit-oh | NA | ≥9.0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 64 | Fmoc-β-ala-d-cit-oh | NA | ≥9.0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 65 | Fmoc-β-ala-Dab-Oh | NA | ≥9.0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 66 | FMOC- (3- (2-Naphthyl) -D-ALA) 2-OH | NA | ≥9.0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 67 | Fmoc-β-A-3- (2-Naphthyl) -d-ACH | NA | ≥9.0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 68 | FMOC- (3- (3-pliidinil) -D-ABA) 2-oh | NA | ≥9.0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 69 | Fmoc-β-ala-3- (3-pliidinil) -D-ala-oh | NA | ≥9.0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 70 | Fmoc- (4-chloro-d-ph) 2-oh | NA | ≥9.0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 71 | Fmoc-β-ala-4-chloro-d-ph shoe | NA | ≥9.0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 72 | Fmoc- (d-4apap (tbucbm)) 2-oh | NA | ≥9.0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 73 | Fmoc-β-ala-d-4apap (tbucbm) -oh | NA | ≥9.0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 74 | Fmoc-aph (l-hor) -ap (l-hor) -oh | NA | ≥9.0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 75 | Fmoc-β-Ala-aph (l-ham) -oh | NA | ≥9.0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 76 | Fmoc-lys (iPr, boc) -ly (ipr, boc) -oh | NA | ≥9.0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 77 | Fmoc-β-ala-lys (ipr, boc) -oh | NA | ≥9.0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 78 | Fmoc-β-ala-aeea-aduh | NA | ≥9.0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 79 | FMOC-Aib-Aib-Oh | NA | ≥9.0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 80 | Fmoc-β-ala-aib-Oh | NA | ≥9.0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 81 | Fmoc-arg-oh | 91000-69-0 | ≥9.0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 82 | H-art (pbf) -oh | 200115-86-2 | ≥9.0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 83 | Fmoc-d-arg-oh | 130752-32-8 | ≥9.0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 84 | Hd - Arg (PBF) -oh | 200116-81-0 | ≥9.0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 85 | Fmoc-homoarg-oh.hcl | 208174-14-14-5 | ≥9.0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 86 | H-homoarg (pbf) -oh | NA | ≥9.0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 87 | FMOC-D-homoarg-Oh | NA | ≥9.0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 88 | Hd-homoarg (pbf) -oh | NA | ≥9.0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 89 | Fmoc-asn-Oh | 71989-16-7 | ≥9.0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 90 | H-asn (trt) -oh | 132388-0-0 | ≥9.0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 91 | Fmoc-chars | 119062-05-4 | ≥9.0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 92 | H-cim (OTBU) -oh | 3057-74-7 | ≥9.0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 93 | Fmoc-cys-oh | 135248-89-4 | ≥9.0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 94 | H-cys (trt) -oh | 2799/7/7 | ≥9.0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 95 | H-cys (acm) -oh.hcl | 28798-28-9 | ≥9.0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 96 | Fmoc-gln-oh | 719898-3 | ≥9.0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 97 | H-gln (trt) -oh | 102747-84-2 | ≥9.0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 98 | Fmoc-glu-oh | 121343-82-62 | ≥9.0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 99 | H-Glu (OTBU) -OH.H2O | 2419--9-9 | ≥9.0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 100 | Fmoc-nya | 1166116-164-4 | ≥9.0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 101 | H-na (trt) -oh | 35146-32-8 | ≥9.0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 102 | Boc-na-oh | 17791-52-5 | ≥9.0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 103 | Fmoc-lys-oh | 105047-45-8 | ≥9.0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 104 | H-lys (boc) -oh | 2418-95-3 | ≥9.0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 105 | H-Lys (alloc) -oh | 6298/3/9 | ≥9.0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 106 | Fmoc-orn-Oh.hcl | 201046-57-3 | ≥9.0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 107 | H-orn (boc) -oh | 13650-49-2 | ≥9.0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 108 | Fmoc-Ser-oh | 73724-45 | ≥9.0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 109 | H-Sern (tbu) -oh | 18822-58-7 | ≥9.0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 110 | H-Sern (trt) -oh | NA | ≥9.0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 111 | Fmoc-th-oh.h2o | 73731-37-0 | ≥9.0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 112 | H-th (tbu) -oh | 4378-13-6 | ≥9.0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 113 | FMOC-TrP-OH | 35737-15-15 | ≥9.0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 114 | H-TrP (boc) -oh | 146645-63-8 | ≥9.0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 115 | Fmoc-d-trp-oh | 86123-11-7 | ≥9.0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 116 | HD-TrP (BC) -OH | 201290-11-1 | ≥9.0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 117 | Fmoc-tyr-o | 92954-90-0 | ≥9.0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 118 | H-tyr (tbu) -oh | 188221--59-8 | ≥9.0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 119 | Fmoc-d-tyr-oh | 112883-29-1 | ≥9.0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 120 | Hd-tyr (et) -oh | NA | ≥9.0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 121 | H-ty (kuring) -oh.hcl | 67423-44-3 | ≥9.0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 122 | Fmoc-d-4apap (cbm) -oh | 324017-22-3 | ≥9.0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 123 | Hd-4apap (tbucbm) -oh | NA | ≥9.0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 124 | Fmoc-lys (ipr) -oh | NA | ≥9.0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 125 | H-lys (ipr, boc) -oh | NA | ≥9.0% | ≤1.0% | ≤8.0% | ≤2.0% |
Kira-kira
Santunan
Tublex nyayogikeun produk kualitas anu saé, upami kualitas naon akdana produk anu digedared ku klien dina kanggung waktu anu dibutuhkeun anu diperyogikeun sareng evalasi anu diperyogikeun ku memi prosedur.
Produksi
Kapasilitas produk Farmasi ngahontal kelas tentang kelas, kapasitas produk kimia dugi 100dsons + kelas, kamampuan dilakukeun pikeun mempermasa di dunya.
Panaliti sareng pamekaran
Unggal taun, aya rencana diatur ku tim R & D ngajalan pikeun ngembangkeun produk anyar anu béda-béda, nalika nargétkeun, unggal anggota bakal ngalaksanakeun di times KPI sareng konsumsial KPI sareng kabijakan anu aya.
